Wealth Enhancement Advisory Services
MBOT icon

Wealth Enhancement Advisory Services’s Microbot Medical MBOT Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-22,279
Closed -$42.1K – 4352
2026
Q2 		$42.1K Buy
+22,279
New +$45.4K ﹤0.01% 3946

Other funds holding MBOT

Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
AlphaCentric Advisors
AlphaCentric Advisors San Juan, Puerto Rico $113M AUM 27.37% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Integrity Alliance
Integrity Alliance Urbandale, Iowa $3.28B AUM 15.79% 1-Year Est. Return
Lazari Capital Management
Lazari Capital Management Woodland Hills, California $339M AUM 25.58% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $184B AUM 51.71% 1-Year Est. Return
Beacon Capital Management LLC (Tennessee)
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $716M AUM 16.7% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Wealth Enhancement Advisory Services's MBOT Position: Q3 2026 in Review

Wealth Enhancement Advisory Services sold out of Microbot Medical (MBOT) in Q3 2026, closing a stake of 22,279 shares — an estimated $42.1K sold.

Wealth Enhancement Advisory Services first reported a position in MBOT in Q2 2026 and held it in 1 quarter. The position peaked at $42.1K in Q2 2026. 29 funds tracked by Wall St. Rank hold MBOT as of Q3 2026.

  • Wealth Enhancement Advisory Services reported no remaining Microbot Medical position as of Q3 2026 after selling out during the quarter.
  • Wealth Enhancement Advisory Services sold 22,279 Microbot Medical shares in Q3 2026, an estimated $42.1K.
  • Wealth Enhancement Advisory Services first reported a position in Microbot Medical in Q2 2026 and held it in 1 quarter.
  • Wealth Enhancement Advisory Services's Microbot Medical position peaked at $42.1K in Q2 2026.
  • 29 funds tracked by Wall St. Rank held Microbot Medical as of Q3 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q3 2026, filed 13 Oct 2026.